APA (7th ed.) Citation

J, R., DL, E., M, O. H., LF, R. Z., & CD, S. (2026). Clinical Performance of a Standardized Two-Step Drug Provocation Test Protocol after Retrospective Application of the EAACI/ENDA 2024 Risk Stratification: A Real-World Cohort Study. International archives of allergy and immunology, 1. https://doi.org/10.1159/iaa/adfag011

Chicago Style (17th ed.) Citation

J, Ramirez-Villamizar, Espinosa-Silva DL, Olaya Hernández M, Ramírez Zuluaga LF, and Serrano-Reyes CD. "Clinical Performance of a Standardized Two-Step Drug Provocation Test Protocol After Retrospective Application of the EAACI/ENDA 2024 Risk Stratification: A Real-World Cohort Study." International Archives of Allergy and Immunology 2026: 1. https://doi.org/10.1159/iaa/adfag011.

MLA (9th ed.) Citation

J, Ramirez-Villamizar, et al. "Clinical Performance of a Standardized Two-Step Drug Provocation Test Protocol After Retrospective Application of the EAACI/ENDA 2024 Risk Stratification: A Real-World Cohort Study." International Archives of Allergy and Immunology, 2026, p. 1, https://doi.org/10.1159/iaa/adfag011.